Skip to content

Natures Sunshine Products Inc

NATR· NasdaqCore metricsCIK 275053

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -0.77%
Market cap
$178.31M
17.33M shares
Filings
1,018
$116.60M
Q3 2026+5.7% FY25 yoy
$1.89M
Q3 2026+153.7% FY25 yoy
$5.28M
Q3 2026+23.1% FY25 yoy
$2.95M
Q3 2026derived+101.3% FY25 yoy
$0.11
Q3 2026+165.0% FY25 yoy
$89.38M
Q3 2026+10.9% FY25 yoy
$178.31M
12.2×
0.4×
1.0×
5.89%
—

Twelve months to Sep 30, 2026 · derived

Price

$10.2948.47%$9.68past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$480.14MFY 2025
$480.14M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$480,144,000reported
FY 20242024-12-31$454,364,000reported
FY 20232023-12-31$445,320,000reported
FY 20222022-12-31$421,910,000reported
FY 20212021-12-31$444,084,000reported
FY 20202020-12-31$385,205,000reported
FY 20192019-12-31$362,215,000reported
FY 20182018-12-31$364,810,000reported
FY 20172017-12-31$342,029,000reported
FY 20162016-12-31$341,159,000reported
FY 20152015-12-31$324,705,000reported
FY 20142014-12-31$366,367,000reported

Capital returns

Dividends and buybacks · FY2012 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$16.31M$16.31M—17.51M sh−5.3%56.5%
FY2024—$8.86M$8.86M—18.48M sh−1.8%61.8%
FY2023—$6.40M$6.40M—18.82M sh−1.2%20.8%
FY2022$0.00$13.57M$13.57M$0.0019.06M sh−2.0%—
FY2021$19.86M$7.43M$27.28M$1.0019.45M sh−1.8%97.6%

Segments

Revenue by Segments, FY2019 to FY2025FY2019Asia · FY2019 · $138.54MEurope · FY2019 · $62.52MLatin America and Other · FY2019 · $22.99MOther · FY2019 · $138.16MFY2020Asia · FY2020 · $138.72MNorth America · FY2020 · $145.48MEurope · FY2020 · $77.69MLatin America and Other · FY2020 · $23.32MAsia · FY2020 · $138.72MEurope · FY2020 · $77.69MLatin America and Other · FY2020 · $23.32MOther · FY2020 · $196.68MFY2021Asia · FY2021 · $176.86MNorth America · FY2021 · $149.75MEurope · FY2021 · $91.54MLatin America and Other · FY2021 · $25.94MOther · FY2021 · $61.40MFY2022Asia · FY2022 · $186.29MNorth America · FY2022 · $133.21MEurope · FY2022 · $78.99MLatin America and Other · FY2022 · $23.41MFY2023Asia · FY2023 · $201.25MNorth America · FY2023 · $139.80MEurope · FY2023 · $81.10MLatin America and Other · FY2023 · $23.16MFY2024Asia · FY2024 · $207.79MNorth America · FY2024 · $138.85MEurope · FY2024 · $84.84MLatin America and Other · FY2024 · $22.88MFY2025Asia · FY2025 · $221.78MNorth America · FY2025 · $143.61MEurope · FY2025 · $93.13MLatin America and Other · FY2025 · $21.62M
LineFY2025ShareChange
Asia$221.78M46%+6.7%
North America$143.61M30%+3.4%
Europe$93.13M19%+9.8%
Latin America and Other$21.62M4.5%−5.5%
Asia———
Europe———
Latin America and Other———
Other———
Total$480.14M

From the 10-K filed Mar 10, 2026NATR

Pharmaceutical preparations

Natures Sunshine Products Inc is the 57th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Natures Sunshine Products Inc · CIK 275053 · Engraved from SEC EDGAR